Zai Lab (ZLAB) Competitors

Qiagen (NYSE:QGEN) and Zai Lab (NASDAQ:ZLAB) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

Is QGEN or ZLAB more profitable?

Qiagen has a net margin of 4.73% compared to Zai Lab's net margin of -76.14%. Qiagen's return on equity of 13.43% beat Zai Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	4.73%	13.43%	8.10%
Zai Lab	-76.14%	-36.97%	-27.10%

Do analysts prefer QGEN or ZLAB?

Qiagen presently has a consensus target price of $51.50, indicating a potential upside of 11.96%. Zai Lab has a consensus target price of $55.00, indicating a potential upside of 111.13%. Given Zai Lab's stronger consensus rating and higher probable upside, analysts clearly believe Zai Lab is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56
Zai Lab	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals hold more shares of QGEN or ZLAB?

70.0% of Qiagen shares are owned by institutional investors. Comparatively, 41.7% of Zai Lab shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 13.9% of Zai Lab shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more volatility and risk, QGEN or ZLAB?

Qiagen has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Zai Lab has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.

Does the media prefer QGEN or ZLAB?

In the previous week, Zai Lab had 4 more articles in the media than Qiagen. MarketBeat recorded 12 mentions for Zai Lab and 8 mentions for Qiagen. Qiagen's average media sentiment score of 0.82 beat Zai Lab's score of 0.62 indicating that Qiagen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zai Lab	3 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, QGEN or ZLAB?

Qiagen has higher revenue and earnings than Zai Lab. Zai Lab is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$1.97B	5.34	$341.30M	$0.39	117.94
Zai Lab	$355.75M	8.01	-$334.62M	-$2.77	-9.40

Does the MarketBeat Community favor QGEN or ZLAB?

Qiagen received 23 more outperform votes than Zai Lab when rated by MarketBeat users. However, 64.20% of users gave Zai Lab an outperform vote while only 60.73% of users gave Qiagen an outperform vote.

Company	Underperform	Outperform
Qiagen	Outperform Votes 249 60.73%	Underperform Votes 161 39.27%
Zai Lab	Outperform Votes 226 64.20%	Underperform Votes 126 35.80%

Summary

Qiagen beats Zai Lab on 11 of the 18 factors compared between the two stocks.